Ningbo Xingwo Intelligent Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Ningbo Xingwo Intelligent Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include DEVLASBA. The owner is based in Ningbo, Zhejiang.

No. 298-300, Qingshaoniangong

Ningbo, Zhejiang 315300 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DEVLASBA
DEVLASBA
Registered 2023

Trademark Classifications

Ningbo Xingwo Intelligent Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Ningbo Xingwo Intelligent Technology Co., Ltd. have?

Ningbo Xingwo Intelligent Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Ningbo Xingwo Intelligent Technology Co., Ltd. file in?

Ningbo Xingwo Intelligent Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Ningbo Xingwo Intelligent Technology Co., Ltd.'s most well-known trademarks?

Ningbo Xingwo Intelligent Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as DEVLASBA. These are among 1 currently registered trademark in the portfolio.

What is Ningbo Xingwo Intelligent Technology Co., Ltd.'s trademark registration success rate?

Ningbo Xingwo Intelligent Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.